Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Internal Medicine · SMYRNA, GA · NPI 1376584888
Verified facts
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
We did not find matching Open Payments records for this doctor in the selected program year.
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 451 | 152 |
| Amlodipine Besylate | Amlodipine Besylate | 400 | 133 |
| Losartan Potassium | Losartan Potassium | 229 | 76 |
| Tamsulosin Hcl | Tamsulosin Hcl | 224 | 76 |
| Levothyroxine Sodium | Levothyroxine Sodium | 220 | 73 |
| Gabapentin | Gabapentin | 214 | 80 |
| Fluticasone Propionate | Fluticasone Propionate | 198 | 99 |
| Lisinopril | Lisinopril | 188 | 60 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 183 | 60 |
| Metformin Hcl | Metformin Hcl | 181 | 65 |
| Escitalopram Oxalate | Escitalopram Oxalate | 174 | 67 |
| Trazodone Hcl | Trazodone Hcl | 172 | 56 |
| Pantoprazole Sodium | Pantoprazole Sodium | 149 | 60 |
| Omeprazole | Omeprazole | 136 | 46 |
| Celecoxib | Celecoxib | 129 | 54 |
| Hydrochlorothiazide | Hydrochlorothiazide | 127 | 45 |
| Furosemide | Furosemide | 124 | 47 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 118 | 37 |
| Simvastatin | Simvastatin | 115 | 36 |
| Duloxetine Hcl | Duloxetine Hcl | 113 | 41 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 109 | 32 |
| Metoprolol Succinate | Metoprolol Succinate | 109 | 38 |
| Carvedilol | Carvedilol | 101 | 35 |
| Pioglitazone Hcl | Pioglitazone Hcl | 79 | 28 |
| Allopurinol | Allopurinol | 73 | 25 |
| Ozempic | Semaglutide | 73 | 18 |
| Alprazolam | Alprazolam | 70 | 19 |
| Metformin Hcl Er | Metformin Hcl | 68 | 26 |
| Montelukast Sodium | Montelukast Sodium | 66 | 25 |
| Finasteride | Finasteride | 58 | 17 |
| Tizanidine Hcl | Tizanidine Hcl | 58 | 26 |
| Pravastatin Sodium | Pravastatin Sodium | 57 | 18 |
| Famotidine | Famotidine | 56 | 18 |
| Eliquis | Apixaban | 55 | 12 |
| Hydralazine Hcl | Hydralazine Hcl | 54 | 15 |
| Clopidogrel | Clopidogrel Bisulfate | 50 | 16 |
| Citalopram Hbr | Citalopram Hydrobromide | 49 | 15 |
| Lorazepam | Lorazepam | 48 | 13 |
| Meloxicam | Meloxicam | 48 | 27 |
| Zolpidem Tartrate | Zolpidem Tartrate | 48 | 13 |
| Nifedipine Er | Nifedipine | 46 | 16 |
| Glipizide | Glipizide | 41 | 13 |
| Potassium Chloride | Potassium Chloride | 41 | 17 |
| Azelastine Hcl | Azelastine Hcl | 37 | 18 |
| Meclizine Hcl | Meclizine Hcl | 37 | 16 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 36 | 22 |
| Metoprolol Tartrate | Metoprolol Tartrate | 35 | 15 |
| Spironolactone | Spironolactone | 35 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 34 | 33 |
| Bupropion Xl | Bupropion Hcl | 34 | 18 |
| Estradiol | Estradiol | 34 | suppressed |
| Januvia | Sitagliptin Phosphate | 34 | 14 |
| Betamethasone Valerate | Betamethasone Valerate | 33 | 14 |
| Bupropion Hcl Sr | Bupropion Hcl | 33 | 12 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 31 | 11 |
| Mounjaro | Tirzepatide | 31 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 30 | suppressed |
| Pregabalin | Pregabalin | 30 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 30 | 11 |
| Sertraline Hcl | Sertraline Hcl | 29 | 11 |
| Atenolol | Atenolol | 28 | 12 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 28 | 25 |
| Xarelto | Rivaroxaban | 28 | suppressed |
| Tradjenta | Linagliptin | 27 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 27 | 15 |
| Farxiga | Dapagliflozin Propanediol | 26 | suppressed |
| Glipizide Er | Glipizide | 26 | suppressed |
| Jardiance | Empagliflozin | 25 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 25 | suppressed |
| Ezetimibe | Ezetimibe | 24 | suppressed |
| Lubiprostone | Lubiprostone | 24 | 12 |
| Valacyclovir | Valacyclovir Hcl | 24 | 11 |
| Clonazepam | Clonazepam | 23 | 11 |
| Doxazosin Mesylate | Doxazosin Mesylate | 23 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 23 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 22 | suppressed |
| Ibuprofen | Ibuprofen | 22 | suppressed |
| Klor-Con M10 | Potassium Chloride | 22 | suppressed |
| Prednisone | Prednisone | 22 | 15 |
| Chlorthalidone | Chlorthalidone | 20 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 20 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 19 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 19 | suppressed |
| Topiramate | Topiramate | 19 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 18 | 11 |
| Linzess | Linaclotide | 18 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 18 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 18 | suppressed |
| Torsemide | Torsemide | 18 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 17 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 17 | suppressed |
| Hydrocortisone | Hydrocortisone | 17 | suppressed |
| Lovastatin | Lovastatin | 17 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 17 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 16 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 16 | suppressed |
| Mirtazapine | Mirtazapine | 16 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 16 | suppressed |
| Testosterone | Testosterone | 16 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 16 | suppressed |
| Trulicity | Dulaglutide | 16 | suppressed |
| Valsartan | Valsartan | 16 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 15 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 15 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 15 | suppressed |
| Novolog Flexpen | Insulin Aspart | 15 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 14 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 14 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 14 | 14 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 14 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 14 | suppressed |
| Temazepam | Temazepam | 14 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 13 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 13 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 13 | suppressed |
| Fluconazole | Fluconazole | 13 | 13 |
| Ipratropium Bromide | Ipratropium Bromide | 13 | suppressed |
| Ketoconazole | Ketoconazole | 13 | suppressed |
| Memantine Hcl | Memantine Hcl | 13 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 13 | suppressed |
| Synthroid | Levothyroxine Sodium | 13 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 13 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 12 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 12 | suppressed |
| Klor-Con M20 | Potassium Chloride | 12 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 12 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 12 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 11 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 11 | suppressed |
| Levetiracetam | Levetiracetam | 11 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Ondansetron Odt | Ondansetron | 11 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error